Medical Condition News

RSS

Young Latinx adults who experience heart-focused anxiety face greater risk for mental health disorders

For coffee drinkers, a common scenario might involve drinking an extra cup only to end up with a racing heart and a subtle reminder to themselves to cut down the caffeine.

21 May 2021

Scientists discover key component to repair the molecular motor of human heart

A team of scientists from Loyola University Chicago's Stritch School of Medicine have discovered a critical component for renewing the heart's molecular motor, which breaks down in heart failure.

20 May 2021

Changes in brain regions can predict the progression of epilepsy, lead to better treatment

Scientists have discovered that the way in which neurons are connected within regions of the brain, can be a better indicator of disease progression and treatment outcomes for people with brain disorders such as epilepsy.

20 May 2021

Blocking TGFβ1 could improve hematopoiesis in AML patients, indicates study

Bone marrow failure due to acute myeloid leukemia (AML) is a significant factor behind the disease's high rate of morbidity and mortality. Previous studies in mice suggest that AML cells inhibit healthy hematopoietic (blood) stem and progenitor cells (HSPC).

20 May 2021

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

An international team, led by researchers from Pompeu Fabra University (UPF) in Barcelona, Spain, David Andreu and Rafael Maldonado, has developed a peptides family that allows delta-9-tetrahydrocannabinol (THC), the main component of Cannabis sativa, to fight pain in mice without side effects.

20 May 2021

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.

20 May 2021

Cancer occurs through multiple steps that resurrect ancient cellular functions, suggests new model

In spite of decades of research, cancer remains an enigma. Conventional wisdom holds that cancer is driven by random mutations that create aberrant cells that run amok in the body.

20 May 2021

Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma

Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference.

20 May 2021

Tobacco smoke exposure in utero and during early childhood can affect children's lung function

Environmental tobacco smoke exposure in utero and during early childhood - especially secondhand smoke - is associated with decreased childhood lung function, according to research presented at the ATS 2021 International Conference.

20 May 2021

About two-fifths of Medicare beneficiaries with COPD have limited access to pulmonary rehabilitation services

Approximately two-fifths of Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) have limited access to pulmonary rehabilitation services due to their distance from rehab centers, according to research presented at the ATS 2021 International Conference.

20 May 2021

Blocking ABCB10 protein in liver cells protects against high blood sugar, fatty liver disease

A new multi-institution study led by a team of researchers at the David Geffen School of Medicine demonstrated that blocking a protein called ABCB10 in liver cells protects against high blood sugar and fatty liver disease in obese mice.

20 May 2021

Are COVID-19-related complications in children explained by abnormal immune responses?

A common theme in reports on COVID-19 around the world has been the large number of children who have not been infected or shown signs of disease. However, though the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes less acute infection in this age group, it is associated with a severe immune-mediated multisystemic illness called multisystem inflammatory syndrome in children (MIS-C).

20 May 2021

Early treatment may prevent clotting in COVID-19 vaccine-related thrombocytopenia

Now, a new report in the Journal of Thrombosis and Hemostasis reveals that timely diagnosis and treatment of this condition may prevent further morbidity and mortality, and enable the vaccine to be used widely with confidence.

20 May 2021

Extensive cancer research data to be presented at the 2021 ASCO Annual Meeting

Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and health outcomes analyses and a designated Comprehensive Cancer Center by the National Cancer Institute, together with RWJBarnabas Health, today announced that data from its cancer clinical research program will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held virtually from June 4-8.

20 May 2021

Study reveals the accuracy of risk stratification scores among patients with unexplained syncope

The Canadian Syncope Risk Score (CSRS) is an accurate validated prediction score for emergency department patients with unexplained syncope.

20 May 2021

UB pharmacy researcher to design real-time algorithm to reduce hospital readmission rates for COPD patients

To lower hospital readmission rates for patients with chronic obstructive pulmonary disease (COPD), University at Buffalo pharmacy researcher David Jacobs has received a $962,000 award from the National Heart, Lung, and Blood Institute to develop a real-time readmission risk prediction algorithm.

20 May 2021

A better understanding of brain fluid movements can help predict and treat Alzheimer's disease

Scientists don't fully understand what causes Alzheimer's disease, but they have a primary suspect.

20 May 2021

Triple-drug therapy can reduce asthma exacerbations, improve control without major adverse events

Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents, and adults with moderate-to-severe asthma.

20 May 2021

Study could serve as guidepost for developing new therapies for Alzheimer's disease

In a major breakthrough, researchers at Massachusetts General Hospital (MGH) have discovered how amyloid beta--the neurotoxin believed to be at the root of Alzheimer's disease (AD)--forms in axons and related structures that connect neurons in the brain, where it causes the most damage.

20 May 2021

Study shows DHA can reduce early preterm births

In the study published in the journal EClinical Medicine, a dose of 1000 mg of DHA may reduce early preterm births significantly compared to 200 mg as found in some prenatal supplements.

20 May 2021

Medical Condition News

Young Latinx adults who experience heart-focused anxiety face greater risk for mental health disorders

Scientists discover key component to repair the molecular motor of human heart

Changes in brain regions can predict the progression of epilepsy, lead to better treatment

Blocking TGFβ1 could improve hematopoiesis in AML patients, indicates study

New peptides allow cannabis-derived drugs to fight pain in mice without side effects

Dupilumab considerably reduced asthma exacerbations in young children, shows VOYAGE trial

Cancer occurs through multiple steps that resurrect ancient cellular functions, suggests new model

Phase 3 trial: New biologic therapy improves outcomes in adults, adolescents with severe asthma

Tobacco smoke exposure in utero and during early childhood can affect children's lung function

About two-fifths of Medicare beneficiaries with COPD have limited access to pulmonary rehabilitation services

Blocking ABCB10 protein in liver cells protects against high blood sugar, fatty liver disease

Are COVID-19-related complications in children explained by abnormal immune responses?

Early treatment may prevent clotting in COVID-19 vaccine-related thrombocytopenia

Extensive cancer research data to be presented at the 2021 ASCO Annual Meeting

Study reveals the accuracy of risk stratification scores among patients with unexplained syncope

UB pharmacy researcher to design real-time algorithm to reduce hospital readmission rates for COPD patients

A better understanding of brain fluid movements can help predict and treat Alzheimer's disease

Triple-drug therapy can reduce asthma exacerbations, improve control without major adverse events

Study could serve as guidepost for developing new therapies for Alzheimer's disease

Study shows DHA can reduce early preterm births

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News